Biologics License Application (BLA)
The application to FDA to market a biological product in the US.
Study designBiomarker
A measurable characteristic that indicates a biological process, disease or response to treatment.
Randomisation and supplyBlinding (single, double, triple)
Keeping participants, investigators or analysts unaware of treatment assignment to prevent bias (single, double, triple blind).
Case Report Form (CRF)
The form, paper or electronic, that records the protocol-required data for each participant.
Data and documentsCDISC
The standards body behind CDASH, SDTM, ADaM and Define-XML, the data formats used for clinical trial submissions.
Data and documentsClinical Data Cleaning
Finding and resolving errors, gaps and inconsistencies in trial data before the database is locked.
Study designClinical Trial Endpoints
The outcomes a trial measures to answer its questions: primary, secondary and exploratory.
Study design and planningClinical Trial Protocol
The document that describes the objectives, design, methodology, statistical considerations and organisation of a trial.
Regulation and registrationClinicalTrials.gov
The public registry and results database of clinical studies run by the US National Library of Medicine.
Outcomes and measurementCOA Types: PRO, ClinRO, ObsRO, PerfO
The four types of clinical outcome assessment: PRO, ClinRO, ObsRO and PerfO.
Ethics and oversightCRO (contract research organization)
A company contracted by a sponsor to run some or all of the operational work of a clinical trial.
Safety and pharmacovigilanceCTCAE
The NCI scale that grades the severity of adverse events from 1 (mild) to 5 (death).
Systems and operationsCTMS
Software that manages trial operations: sites, milestones, monitoring visits, contracts and payments.
Inclusion and Exclusion Criteria
The protocol rules that decide who can and cannot join a trial.
Ethics and oversightInformed Consent
The process by which a person is told about a study and freely agrees to take part, usually documented by signature.
Ethics and oversightInstitutional Review Board (IRB)
The independent committee that reviews research to protect participants' rights and welfare.
Randomisation and supplyIRT / IWRS
Interactive response technology: systems that randomise participants and manage trial drug supply.
Phases of Clinical Trials
The staged sequence of human studies (Phase 1 to 4) that tests a new treatment for safety, dose, efficacy and long-term effects.
Study designPragmatic Clinical Trial
A trial designed to test effectiveness in real-world practice rather than ideal conditions.
Study designPrimary Endpoint
The main outcome a trial is designed to answer, which also drives its sample size.
Outcomes and endpointsPROM
A questionnaire or scale that captures a health outcome straight from the patient.
Randomization
Assigning participants to trial arms by chance so the groups are comparable.
Outcomes and measurementReference Interval (Normal Range)
The range of lab values expected in a healthy reference population, often called the normal range.
Monitoring and qualityRisk-Based Monitoring (RBM)
Focusing monitoring effort on the data and processes that matter most.
SaMD
Software with a medical purpose that runs on its own, without being part of a hardware medical device.
Study designSample Size Calculation
Working out how many participants a trial needs to detect the effect it is looking for.
Safety and pharmacovigilanceSerious adverse event (SAE)
An adverse event that results in death, a life-threatening event, hospitalisation, disability, a birth defect or another important medical event.
Monitoring and qualitySource Data Verification (SDV)
Checking that CRF data matches the original source records.
Study designStatistical Analysis Plan (SAP)
The document that sets out in advance exactly how the trial data will be analysed.
By topic
In-depth guides
ALCOA+
The data integrity principles regulators apply to trial records.
21 CFR Part 11
FDA rules for electronic records and electronic signatures.
Computer system validation (CSV)
Showing a system is fit for its intended use.
eCOA
Electronic clinical outcome assessments.
RTSM
Randomisation and trial supply management.
CTMS
Clinical trial management systems, compared with EDC.
eTMF
Electronic trial master files, compared with EDC.
Decentralized clinical trial (DCT)
Trials with activities away from traditional sites.
ICH E6(R3)
The latest revision of Good Clinical Practice.
EU CTR
The EU Clinical Trials Regulation and CTIS.
Bayesian trial design
Designs that update evidence as data accrue.
Diversity action plan
Plans for enrolling representative populations.
CRFs, edit checks, SDV, randomisation and database lock, all in one free sandbox.
Start free